These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 15601331)

  • 1. Three-dimensional conformal radiotherapy in the treatment of prostate cancer in Australia and New Zealand: Report on a survey of radiotherapy centres and the proceedings of a consensus workshop.
    Tai KH; Duchesne G; Turner S; Kneebone A; See A; Gogna K; Berry M
    Australas Radiol; 2004 Dec; 48(4):502-8. PubMed ID: 15601331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Australian and New Zealand three-dimensional conformal radiation therapy consensus guidelines for prostate cancer.
    Skala M; Berry M; Duchesne G; Gogna K; Tai KH; Turner S; Kneebone A; Rolfo A; Haworth A
    Australas Radiol; 2004 Dec; 48(4):493-501. PubMed ID: 15601330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Australian & New Zealand Faculty of Radiation Oncology Genito-Urinary Group: 2010 consensus guidelines for definitive external beam radiotherapy for prostate carcinoma.
    Hayden AJ; Martin JM; Kneebone AB; Lehman M; Wiltshire KL; Skala M; Christie D; Vial P; McDowall R; Tai KH;
    J Med Imaging Radiat Oncol; 2010 Dec; 54(6):513-25. PubMed ID: 21199428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RE: Three-dimensional conformal radiotherapy in the treatment of prostate cancer in Australia and New Zealand: report on a survey of radiotherapy centres by K-H Tai et al.
    Izard MA
    Australas Radiol; 2005 Jun; 49(3):256-7. PubMed ID: 15932473
    [No Abstract]   [Full Text] [Related]  

  • 5. Australia-wide comparison of intensity modulated radiation therapy prostate plans.
    Skala M; Holloway L; Bailey M; Kneebone A
    Australas Radiol; 2005 Jun; 49(3):222-9. PubMed ID: 15932465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing two strategies of dynamic intensity modulated radiation therapy (dIMRT) with 3-dimensional conformal radiation therapy (3DCRT) in the hypofractionated treatment of high-risk prostate cancer.
    Yuen J; Rodrigues G; Trenka K; Coad T; Yartsev S; D'Souza D; Lock M; Bauman G
    Radiat Oncol; 2008 Jan; 3():1. PubMed ID: 18179695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Constraints and dosage for prostate cancer patients treated with conformal radiotherapy and intensity modulated radiation therapy].
    Chauvet I; Gaboriaud G; Pontvert D; Zefkili S; Giraud P; Rosenwald JC; Cosset JM
    Cancer Radiother; 2004 Dec; 8(6):337-51. PubMed ID: 15619378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk-adapted androgen deprivation and escalated three-dimensional conformal radiotherapy for prostate cancer: Does radiation dose influence outcome of patients treated with adjuvant androgen deprivation? A GICOR study.
    Zapatero A; Valcárcel F; Calvo FA; Algás R; Béjar A; Maldonado J; Villá S
    J Clin Oncol; 2005 Sep; 23(27):6561-8. PubMed ID: 16170164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A dose-escalation trial with the adaptive radiotherapy process as a delivery system in localized prostate cancer: analysis of chronic toxicity.
    Brabbins D; Martinez A; Yan D; Lockman D; Wallace M; Gustafson G; Chen P; Vicini F; Wong J
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):400-8. PubMed ID: 15667959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality improvements in prostate radiotherapy: outcomes and impact of comprehensive quality assurance during the TROG 03.04 'RADAR' trial.
    Kearvell R; Haworth A; Ebert MA; Murray J; Hooton B; Richardson S; Joseph DJ; Lamb D; Spry NA; Duchesne G; Denham JW
    J Med Imaging Radiat Oncol; 2013 Apr; 57(2):247-57. PubMed ID: 23551788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative treatment planning on localized prostate carcinoma conformal photon- versus proton-based radiotherapy.
    Mock U; Bogner J; Georg D; Auberger T; Pötter R
    Strahlenther Onkol; 2005 Jul; 181(7):448-55. PubMed ID: 15995838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assuring high quality treatment delivery in clinical trials - Results from the Trans-Tasman Radiation Oncology Group (TROG) study 03.04 "RADAR" set-up accuracy study.
    Haworth A; Kearvell R; Greer PB; Hooton B; Denham JW; Lamb D; Duchesne G; Murray J; Joseph D
    Radiother Oncol; 2009 Mar; 90(3):299-306. PubMed ID: 19017549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensity-modulated radiotherapy improves lymph node coverage and dose to critical structures compared with three-dimensional conformal radiation therapy in clinically localized prostate cancer.
    Wang-Chesebro A; Xia P; Coleman J; Akazawa C; Roach M
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):654-62. PubMed ID: 17011444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Australian & New Zealand Faculty of Radiation Oncology Genito-Urinary Group: 2011 consensus guidelines for curative radiotherapy for urothelial carcinoma of the bladder.
    Hindson BR; Turner SL; Millar JL; Foroudi F; Gogna NK; Skala M; Kneebone A; Christie DR; Lehman M; Wiltshire KL; Tai KH;
    J Med Imaging Radiat Oncol; 2012 Feb; 56(1):18-30. PubMed ID: 22339742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Technological advances in radiotherapy for the treatment of localised prostate cancer.
    Mangar SA; Huddart RA; Parker CC; Dearnaley DP; Khoo VS; Horwich A
    Eur J Cancer; 2005 Apr; 41(6):908-21. PubMed ID: 15808957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality assurance in the 22991 EORTC ROG trial in localized prostate cancer: dummy run and individual case review.
    Matzinger O; Poortmans P; Giraud JY; Maingon P; Budiharto T; van den Bergh AC; Davis JB; Musat E; Ataman F; Huyskens DP; Gulyban A; Bolla M;
    Radiother Oncol; 2009 Mar; 90(3):285-90. PubMed ID: 19038468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-prostatectomy radiation therapy: consensus guidelines of the Australian and New Zealand Radiation Oncology Genito-Urinary Group.
    Sidhom MA; Kneebone AB; Lehman M; Wiltshire KL; Millar JL; Mukherjee RK; Shakespeare TP; Tai KH
    Radiother Oncol; 2008 Jul; 88(1):10-9. PubMed ID: 18514340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of benefit from a short course of androgen deprivation for unfavorable prostate cancer patients treated with an accelerated hypofractionated regime.
    Martinez AA; Demanes DJ; Galalae R; Vargas C; Bertermann H; Rodriguez R; Gustafson G; Altieri G; Gonzalez J
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1322-31. PubMed ID: 16029788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IMRT versus conventional 3DCRT on prostate and normal tissue dosimetry using an endorectal balloon for prostate immobilization.
    Vlachaki MT; Teslow TN; Amosson C; Uy NW; Ahmad S
    Med Dosim; 2005; 30(2):69-75. PubMed ID: 15922172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality assurance of the 22961 EORTC trial. A phase III study of the optimal combination of hormonal adjuvant treatment by LHRH analogue and radiation therapy for the management of locally advanced prostate cancer: the dummy run.
    Kouloulias VE; Giraud JY; Davis BJ; Dusserre A; Zurlo A; Bolla M
    Radiother Oncol; 2004 Oct; 73(1):11-20. PubMed ID: 15465141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.